It's coiled...ready for a breakout from the triple-bottom trading range (0.32-0.37) we've been in for the past 3 months.
Just 6-10 weeks till the ultimate verification of the ResApp Dx technology is announced.
With a high probability of USA clinical study success, the downside risk is minimal at this point and the upside is massive.
RAP charting, page-7915
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
